The personal Sites for teaching stuff members

C.V

Welcome to my personal page

Birth Date:11/22/1981
Phone No:01003715958
E-mail:amany.azoz@pharm.bsu.edu.eg
Address:258, Street no. 15, Beni-Suef El-Gedida, Beni-Suef, Egypt

Publications

3/20/2018

Therapeutics2

Therapeutics 2 For Clinical Pharmacy Students By Dr/ Amany Abd El-Khalek Aly Azouz Lecturer of Pharmacology & Toxicology Faculty of Pharmacy, Beni-Suef University

Researches

Research areas

pharmacology and toxicology

Contact US

You can contact us through the following address

Sender E-mail

required field invalid mail address

Content of the message

Amany Abd El-Khalek Aly Azouz

C.V

Publications

Therapeutics2

Researches

Different Protective Effects of Trimetazidine against Renal Ischemia/Reperfusion Injury in Rats

1-(4-Methane(amino)sulfonylphenyl)-3-(4-substituted-phenyl)-5-(4-trifluoromethylphenyl)-1H-2-pyrazolines/pyrazoles as potentialanti-inflammatory agents.

Synthesis, cyclooxygenase inhibition, anti-inflammatoryevaluation and ulcerogenic liability of new 1-phenylpyrazolo[3,4-d]pyrimidine derivatives.

Synthesis, Cyclooxygenase Inhibition, Anti-InflammatoryEvaluation, and Ulcerogenic Liability of New 1,3,5-Triarylpyrazoline Derivatives Possessing a MethanesulfonylPharmacophore.

Discovery of a COX-2 selective inhibitor hit with anti-inflammatory activity and gastric ulcer protective effect.

Novel tetrazole and cyanamide derivatives as inhibitors of cyclooxygenase-2 enzyme: design, synthesis, anti-inflammatoryevaluation, ulcerogenic liability and docking study.

Synthesis, anti-inflammatory, cyclooxygenases inhibitionsassays and histopathological study of poly-substituted 1,3,5-triazines: Confirmation of regiospecific pyrazole cyclization by HMBC.

Corrigendum to "Synthesis and biological evaluations of new nitric oxide-anti-inflammatory drug hybrids" [Bioorg Med Chem Lett (2017) 4358-4369].

Novel pyrimidine-pyridine hybrids: Synthesis, cyclooxygenaseinhibition, anti-inflammatory activity and ulcerogenic liability.

Design, synthesis, analgesic, anti-inflammatory activity of novelpyrazolones possessing aminosulfonyl pharmacophore as inhibitors of COX-2/5-LOX enzymes: Histopathological and docking studies.

Targeting Keap-1/Nrf-2 pathway and cytoglobin as a potentialprotective mechanism of diosmin and pentoxifylline againstcholestatic liver cirrhosis.

Hepatoprotective effects of diosmin and/or sildenafil againstcholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway.

Research areas

Contact US